TAK ALG-25 Pill - red oval, 9mm
Pill with imprint TAK ALG-25 is Red, Oval and has been identified as Alogliptin Benzoate 25 mg. It is supplied by Perrigo New York Inc.
Alogliptin is used in the treatment of Type 2 Diabetes and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Alogliptin 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TAK ALG-25
Alogliptin Benzoate
- Imprint
- TAK ALG-25
- Strength
- 25 mg
- Color
- Red
- Size
- 9.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Perrigo New York Inc.
- Inactive Ingredients
-
mannitol,
microcrystalline cellulose,
croscarmellose sodium,
magnesium stearate,
hypromellose 2910 (6 mPa.s),
titanium dioxide,
polyethylene glycol 8000,
ferric oxide red,
ferrosoferric oxide,
shellac,
butyl alcohol,
alcohol
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 45802-0150 | Perrigo Company |
| 64764-0250 | Takeda Pharmaceutical Company Limited |
Related images for "TAK ALG-25"
More about alogliptin
- Check interactions
- Compare alternatives
- Reviews (9)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: dipeptidyl peptidase 4 inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.